Related Experiment Video
Updated: Jan 21, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Updates in the Diagnosis and Management of Giant Cell Arteritis
Surabhi Uppal1, Mohanad Hadi2, Sheetal Chhaya3,4
1Department of Internal Medicine, St. Joseph's Hospital and Medical Center, 500 W. Thomas Road, Phoenix, AZ, 85013, USA.
Insights
Giant cell arteritis (GCA) is a large vessel vasculitis affecting older adults. Current treatments, mainly glucocorticoids, have side effects, prompting research into safer alternatives and better outcome prediction.
Area of Science:
- Rheumatology
- Internal Medicine
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) is a systemic large vessel vasculitis predominantly affecting the elderly.
- It can lead to severe complications, including irreversible vision loss.
- Current treatment options for GCA are limited and associated with significant long-term adverse effects.
Purpose of the Study:
- To review the pathophysiology and clinical aspects of GCA.
- To discuss the most recent data regarding the diagnosis and treatment of GCA.
- To highlight emerging therapeutic strategies and diagnostic advancements.
Main Methods:
- Literature review of recent studies on GCA.
- Analysis of current diagnostic criteria and imaging techniques.
- Evaluation of emerging and established treatment modalities.
Main Results:
- Glucocorticoids remain the primary treatment for GCA.
- Alternative agents are being explored to minimize glucocorticoid toxicity and improve patient outcomes.
- Further research is needed to standardize treatment duration and assess long-term efficacy of new therapies.
Conclusions:
- Optimizing GCA management requires balancing disease control with minimizing treatment-related adverse effects.
- Identifying predictive risk factors for individual patient outcomes is crucial.
- Ongoing research aims to refine diagnostic accuracy and therapeutic efficacy for GCA.
Purpose Of Review:
Giant cell arteritis is a systemic large vessel vasculitis that affects the older population and can cause progressive and at times, devastating complications including vision loss. While this has been commonly diagnosed and treated among vasculitides, the treatment options are limited and can have long-term adverse effects. The purpose of our review on GCA is to identify and discuss the pathophysiology and clinical aspects of GCA as they relate to the most recent data. The review will describe any new data on the diagnosis and treatment of this systemic large vessel vasculitis.
Recent Findings:
The latest data suggests that the mainstay of treatment of GCA remains glucocorticoids but alternate agents are being identified and used in an attempt to reduce the cumulative exposure to glucocorticoids and reduce treatment-related adverse effects while managing and maintaining remission of this systemic disease. There is much more information to collect in terms of identification and standardization of the optimal length of time to treat with glucocorticoids as well as regarding the long-term efficacy of alternate treatments. In addition, investigation continues to identify measureable risk factors to predict outcomes of individual patients with this diagnosis.
Related Concept Videos
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Documentation of Nursing Diagnosis
In some settings, data-driven computerized decision support systems are in place, allowing for more accurate nursing diagnoses. The database within one of these systems includes diagnostic labels defining characteristics, activities, and indicators for nursing. A nurse enters...
Formulating and Validating Nursing Diagnosis I
There are thirteen domains...
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Diabetes: Symptoms, Diagnosis, and Complications

